BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37377068)

  • 1. Performance evaluation of SARS-CoV-2 antigen detection in the post-pandemic era: multi-laboratory assessment.
    Chen Y; Feng L; Han Y; Zhao Z; Diao Z; Huang T; Ma Y; Feng W; Li J; Li Z; Liu C; Chang L; Li J; Zhang R
    Clin Chem Lab Med; 2023 Nov; 61(12):2237-2247. PubMed ID: 37377068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Quality Assessment for Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detection in Chongqing, China.
    Guo Y; Li T; Liu S; Wang K; Zhang Y; Wang L; Liao P
    Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic.
    Donoso Mantke O; Corman VM; Taddei F; McCulloch E; Niemeyer D; Grumiro L; Dirani G; Wallace PS; Drosten C; Sambri V; Niesters HGM
    J Clin Virol; 2022 Sep; 154():105222. PubMed ID: 35797940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study.
    Buchta C; Aberle SW; Allerberger F; Benka B; Görzer I; Griesmacher A; Hübl W; Huf W; Kapiotis S; Müller MM; Neuwirth E; Puchhammer-Stöckl E; Weseslindtner L; Camp JV
    Lancet Microbe; 2023 Dec; 4(12):e1015-e1023. PubMed ID: 37979591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection.
    Ast V; Costina V; Eichner R; Bode A; Aida S; Gerhards C; Thiaucourt M; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M; Haselmann V
    J Clin Microbiol; 2021 Aug; 59(9):e0055921. PubMed ID: 34190575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Four Strategies for SARS-CoV-2 Detection: Characteristics and Prospects.
    Chen Y; Ma Y; Han Y; Diao Z; Chang L; Li J; Zhang R
    Microbiol Spectr; 2022 Dec; 10(6):e0214322. PubMed ID: 36287010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of German external quality assessment schemes for SARS-CoV-2 antigen detection.
    Vierbaum L; Wojtalewicz N; Grunert HP; Zimmermann A; Scholz A; Goseberg S; Kaiser P; Duehring U; Drosten C; Corman V; Niemeyer D; Rabenau HF; Obermeier M; Nitsche A; Michel J; Puyskens A; Huggett JF; O'Sullivan DM; Busby E; Cowen S; Vallone PM; Cleveland MH; Falak S; Kummrow A; Schellenberg I; Zeichhardt H; Kammel M
    Sci Rep; 2023 Aug; 13(1):13206. PubMed ID: 37580353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [National external quality assessment for molecular detection of severe acute respiratory syndrome coronavirus 2 Delta variant].
    Han YX; Chen YQ; Li JM; Zhang R
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):216-221. PubMed ID: 35042291
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories.
    Mögling R; Fischer C; Stanoeva KR; Melidou A; Almeida Campos AC; Drosten C; Biere B; Meijer A; Kraus A; Reusken CBEM; Drexler JF
    J Clin Microbiol; 2022 Dec; 60(12):e0126122. PubMed ID: 36445090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The versatility of external quality assessment for the surveillance of laboratory and
    Buchta C; Camp JV; Jovanovic J; Chiba P; Puchhammer-Stöckl E; Mayerhofer M; Plicka H; Lercher A; Popa AM; Endler L; Bergthaler A; Huf W; Benka B; Delatour V; Müller MM; Griesmacher A; Aberle SW; Görzer I
    Clin Chem Lab Med; 2021 Sep; 59(10):1735-1744. PubMed ID: 34187131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
    Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
    Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020.
    Fischer C; Mögling R; Melidou A; Kühne A; Oliveira-Filho EF; Wolff T; Reiche J; Broberg E; Drosten C; Meijer A; Leitmeyer K; Drexler JF; Reusken CBEM
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5.
    Krenn F; Dächert C; Badell I; Lupoli G; Öztan GN; Feng T; Schneider N; Huber M; Both H; Späth PM; Muenchhoff M; Graf A; Krebs S; Blum H; Durner J; Czibere L; Kaderali L; Keppler OT; Baldauf HM; Osterman A
    Med Microbiol Immunol; 2023 Oct; 212(5):323-337. PubMed ID: 37561225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples.
    Buchta C; Camp JV; Jovanovic J; Puchhammer-Stöckl E; Strassl R; Müller MM; Griesmacher A; Aberle SW; Görzer I
    Clin Chem Lab Med; 2022 Jul; 60(8):1308-1312. PubMed ID: 35599330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme.
    Sciacovelli L; Padoan A; Secchiero S; Plebani M
    Clin Chem Lab Med; 2021 Oct; 59(11):1878-1884. PubMed ID: 34348424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
    Haselmann V; Özçürümez MK; Klawonn F; Ast V; Gerhards C; Eichner R; Costina V; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M
    Clin Chem Lab Med; 2020 Aug; 58(12):2121-2130. PubMed ID: 32853163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)-Pitfalls of Routine Application.
    Kittel M; Eichner R; Aida S; Bode A; Ast V; Kessler A; Neumaier M; Wölfel R; Haselmann V
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.
    Osterman A; Badell I; Dächert C; Schneider N; Kaufmann AY; Öztan GN; Huber M; Späth PM; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Czibere L; Durner J; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2023 Feb; 212(1):13-23. PubMed ID: 36370197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External quality assessment for molecular detection of Ureaplasma urealyticum in China.
    Han Y; Jiang J; Ma Y; Chen Y; Diao Z; Huang T; Li J; Feng W; Li Z; Li J; Zhang R
    Clin Chim Acta; 2024 Apr; 557():117864. PubMed ID: 38461865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.